research use only

Sorafenib (BAY 43-9006) Raf/VEGFR inhibitor

Cat.No.S7397

Sorafenib is a multikinase inhibitor of Raf-1 and B-Raf with IC50 of 6 nM and 22 nM in cell-free assays, respectively. Sorafenib inhibits VEGFR-2, VEGFR-3, PDGFR-β, Flt-3 and c-KIT with IC50 of 90 nM, 20 nM, 57 nM, 59 nM and 68 nM, respectively. Sorafenib induces autophagy and apoptosis and activates ferroptosis with anti-tumor activity.
Jump to

Quality Control

Batch: Purity: 99.91%
99.91
Q&A of Sorafenib (BAY 43-9006): Insights Rooted in Extensive Publications, Every Answer Cited
AI is thinking... 0%

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 92 mg/mL (197.92 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about Sorafenib (BAY 43-9006) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about Sorafenib (BAY 43-9006) working concentrations for cell culture treatment

×

Selectivity & Specificity

Sorafenib (BAY 43-9006) is a potent inhibitor of VEGFR-2 kinase (0.22±0.09 mM), VEGFR-2 (0.84 mM), VEGFR2 kinase (8.99 nM), EGFR kinase (0.76 mgm L−1), RAF1 (6 nM). Sorafenib (BAY 43-9006) exhibits the greatest inhibitory potency toward RAF1 (IC50 = 6 nM).

Read more about selectivity & specificity

Mechanism of Action

Information Sorafenib is an ATP-competitive multikinase inhibitor. It affects MAPK signaling by blocking ATP sites, inhibiting tumor growth.

Read more about Sorafenib (BAY 43-9006) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about Sorafenib (BAY 43-9006) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 464.82 Formula

C21H16ClF3N4O3

Storage (From the date of receipt)
CAS No. 284461-73-0 Download SDF Storage of Stock Solutions

Synonyms NSC-724772,BAY 43-9006 Smiles CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about Sorafenib (BAY 43-9006)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.